Microarray analysis of Foxa2 mutant mouse embryos reveals novel gene expression and inductive roles for the gastrula organizer and its derivatives by Tamplin, Owen J et al.
BioMed  Central
Page 1 of 19
(page number not for citation purposes)
BMC Genomics
Open Access Research article
Microarray analysis of Foxa2 mutant mouse embryos reveals novel 
gene expression and inductive roles for the gastrula organizer and 
its derivatives
Owen J Tamplin†1,2, Doris Kinzel†3, Brian J Cox1, Christine E Bell4, 
Janet Rossant1,2,5 and Heiko Lickert*3
Address: 1Program in Developmental and Stem Cell Biology, Research Institute, The Hospital for Sick Children, 555 University Avenue, Toronto, 
Ontario, M5G 1X8, Canada, 2Department of Molecular Genetics, Medical Sciences Building, 1 King's College Circle, University of Toronto, 
Toronto, Ontario, M5S 1A8, Canada, 3Institute of Stem Cell Research, Helmholtz Zentrum München, German Research Center for Environmental 
Health (GmbH), Ingolstädter Landstr 1, 85764 Neuherberg, Germany, 4Samuel Lunenfeld Research Institute, Mount Sinai Hospital, 600 
University Avenue, Toronto, Ontario, M5G 1X5, Canada and 5Department of Obstetrics and Gynecology, 92 College Street, University of Toronto, 
Toronto, Ontario, M5G 1L4, Canada
Email: Owen J Tamplin - owen.tamplin@utoronto.ca; Doris Kinzel - doris.kinzel@helmholtz-muenchen.de; Brian J Cox - b.cox@utoronto.ca; 
Christine E Bell - christinewitchell@gmail.com; Janet Rossant - janet.rossant@sickkids.ca; Heiko Lickert* - heiko.lickert@helmholtz-
muenchen.de
* Corresponding author    †Equal contributors
Abstract
Background: The Spemann/Mangold organizer is a transient tissue critical for patterning the gastrula stage
vertebrate embryo and formation of the three germ layers. Despite its important role during development, there
are still relatively few genes with specific expression in the organizer and its derivatives. Foxa2 is a forkhead
transcription factor that is absolutely required for formation of the mammalian equivalent of the organizer, the
node, the axial mesoderm and the definitive endoderm (DE). However, the targets of Foxa2 during
embryogenesis, and the molecular impact of organizer loss on the gastrula embryo, have not been well defined.
Results: To identify genes specific to the Spemann/Mangold organizer, we performed a microarray-based screen
that compared wild-type and Foxa2 mutant embryos at late gastrulation stage (E7.5). We could detect genes that
were consistently down-regulated in replicate pools of mutant embryos versus wild-type, and these included a
number of known node and DE markers. We selected 314 genes without previously published data at E7.5 and
screened for expression by whole mount in situ hybridization. We identified 10 novel expression patterns in the
node and 5 in the definitive endoderm. We also found significant reduction of markers expressed in secondary
tissues that require interaction with the organizer and its derivatives, such as cardiac mesoderm, vasculature,
primitive streak, and anterior neuroectoderm.
Conclusion: The genes identified in this screen represent novel Spemann/Mangold organizer genes as well as
potential Foxa2 targets. Further investigation will be needed to define these genes as novel developmental
regulatory factors involved in organizer formation and function. We have placed these genes in a Foxa2-
dependent genetic regulatory network and we hypothesize how Foxa2 may regulate a molecular program of
Spemann/Mangold organizer development. We have also shown how early loss of the organizer and its inductive
properties in an otherwise normal embryo, impacts on the molecular profile of surrounding tissues.
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Background
The organizer is a highly specialized and transient struc-
ture that has been found in all studied vertebrates. It was
originally discovered in amphibians by Spemann and
Mangold in 1924 by its ability to induce much of a sec-
ondary body axis when transplanted to a host embryo [1].
These experiments were repeated with equivalent tissues
in the chick (Hensen's node; [2]), zebrafish (shield; [3]),
and mouse (node; [4]), demonstrating that organizer
function is highly conserved and is essential for patterning
of the basic body plan during gastrulation. In mouse, the
early gastrula organizer (EGO) forms just anterior to the
emerging primitive streak (PS) at E6.5, then gives rise to
the mid-gastrula organizer (MGO) as the PS elongates
towards the distal tip of the mouse embryo, and finally
forms the morphologically visible node at E7.5 [5]. These
organizer cell populations contribute to the axial meso-
derm and notochord, and are the source of DE that dis-
places the embryonic visceral endoderm (VE) into the
extra-embryonic region (reviewed [6]). Although the
organizer has been studied for more than 80 years, there
are still relatively few genes that have defined expression
in this highly specialized tissue.
One important and conserved organizer-specific gene is
Foxa2, which is first expressed in the mouse embryo at
E6.5 in the EGO and the anterior VE [7-9]. As gastrulation
proceeds, Foxa2 is expressed in the later organizer popula-
tions (MGO and node) and organizer derivatives (ante-
rior mesendoderm (AME), notochord, DE and floor
plate). Foxa2 is absolutely required in these tissues, as they
do not form in the Foxa2 null embryo [10,11]. Foxa2 null
embryos die between E7.5 and E9.5 due to embryonic
patterning defects of the primary body axes. Foxa2 has an
additional function in the VE for proper elongation of the
PS, a function that can be rescued in a Foxa2  mutant
embryo by restoration of wild-type VE [12]. As an indica-
tion of its conserved importance among vertebrates, Foxa2
has organizer-specific homologues in zebrafish [13,14],
Xenopus [15], and chicken [16]. Despite its conserved and
important functions, the only defined targets of Foxa2 in
the early embryo are Shh [17,18] and Otx2 [19], leaving
many open questions regarding the downstream targets of
Foxa2 in vertebrate development. Furthermore, the lack of
markers for organizer derivatives, particularly the DE, is a
major obstacle in our understanding of the molecular
pathways that underlie differentiation of distinct lineages
in the early embryo [20]. This is of particular significance
when attempting to coax embryonic stem (ES) cells into
specific cell types for therapeutic applications [21,22].
A number of groups have designed screens to identify
regionally specific transcripts within the mouse gastrula
embryo, as well as novel molecular markers of node,
AME, and DE [23-28]. Transcriptional profiling of the
embryo has been done using subtractive cDNA libraries,
serial analysis of gene expression (SAGE), and microar-
rays. These techniques, in conjunction with micro-dissec-
tion, flow cytometry, and wild-type versus mutant
comparison, have highlighted the molecular differences
between tissues and cell types in the gastrula. Although
these screens were highly productive, they by no means
reached saturation and each study contributed its own set
of novel markers depending on the design and limitations
of each approach. This suggested to us that there were still
many more genes to be identified in the tissues derived
from the mouse gastrula organizer.
In this study, we present a functionally based microarray
screen to identify novel molecular markers of the node,
AME, and DE. We compared total RNA from pools of
wild-type and Foxa2 mutant embryos at E7.5. We could
detect genes whose levels were significantly reduced in
Foxa2 mutant embryos due to the absence of organizer-
derived tissues. The genes we detected represent putative
targets of Foxa2 or indirect targets due to the absence of
organizer tissue. Based on the microarray results, we con-
ducted whole mount in situ hybridization screens to iden-
tify novel gene expression patterns. Finally, we placed our
results in the context of a gene regulatory network of
organizer development.
Results
Microarray Analysis
To identify novel genes implicated in organizer and endo-
derm formation, we performed a differential gene expres-
sion comparison of wild-type and Foxa2 null embryos at
E7.5. Foxa2 null embryos were derived from Foxa2 null ES
cells [12] using the tetraploid complementation tech-
nique [29,30]. Briefly, this technique involves aggregating
ES cells (GFP-) with wild-type tetraploid host embryos
(GFP+), culturing the chimeric embryos to blastocyst
stage, then transferring back to pseudo-pregnant recipient
mothers (Figure 1). In these experiments, the ES cells con-
tribute to the epiblast and the tetraploid host will contrib-
ute to the extra-embryonic tissues, including the VE. The
embryos are then dissected at E7.5 and screened for GFP-
ES cell contribution to the epiblast. In our experiments,
this technique has the advantage of rescuing the function
of Foxa2 in the VE, allowing proper elongation of the PS,
and analysis of Foxa2 function exclusively in the embryo
proper [12]. The technique also allowed us to rapidly col-
lect litters of entirely homozygous null embryos (~50 gas-
trula stage E7.25–E7.75 embryos per experiment).
Furthermore, total RNA could be isolated without the
need for amplification before hybridization to Affymetrix
GeneChip microarrays. We initially used the U74Av2
array platform (~12,000 transcripts represented), and
then to expand the scope of our study, we re-hybridized
the same biological samples to the whole genomeBMC Genomics 2008, 9:511 http://www.biomedcentral.com/1471-2164/9/511
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MOE430v2 array platform (~39,000 transcripts repre-
sented) when it became available. We performed the array
experiments on two biological replicate pools each of
Foxa2 null and wild-type epiblasts. We also collected a
third biological replicate pool of Foxa2 mutant and wild-
type embryos that we could use for independent quantita-
tive validation of gene expression level changes (see
below).
After normalization and filtering of the U74Av2 microar-
ray data, we scored probe sets as consistently reduced in
Foxa2 null embryos compared to wild-type, if they had a
significant change in two out of four cross comparisons (p
≤ 0.01; see Methods for details). We hypothesized that
these genes would represent direct or indirect targets of
Foxa2, due to loss of activation by Foxa2 or loss of organ-
izer-derived tissues, respectively. Our Foxa2  mutant
microarrays also detected many up-regulated genes (data
not shown), which could represent putative target genes
repressed by Foxa2. There is evidence that Foxa2 acts as a
repressor [31], however in our experiments these results
are confounded and would be difficult to analyze. This is
because a Foxa2  mutant epiblast derived by tetraploid
complementation does not displace its wild-type VE, and
when compared to a wild-type epiblast that does displace
its VE, the mutant appears to be highly enriched for VE
markers (data not shown); this makes it impossible to dis-
tinguish between genuine up-regulated genes, and genes
up-regulated due to VE enrichment. Accordingly, we
focused on the genes with reduced levels in Foxa2 mutant
embryos, and could identify a number of known markers
of the node, AME and DE (Table 1). A number of these
known markers were also previously validated in the liter-
ature as being reduced or absent in Foxa2 null embryos
(Table 1).
We found Foxa1 transcript, another forkhead transcrip-
tion factor that follows Foxa2 expression in the AME and
DE [7-9], was reduced in the Foxa2 null embryo. This is
consistent with previous data that showed Foxa1  is
reduced in both Foxa2 null embryos [10] and embyroid
bodies (EBs) derived from Foxa2 null ES cells [32]. We
also found reduction of Brachyury  (T) levels, which is
expressed in the PS, node and AME at E7.5 [33]. This is
consistent with loss of Brachyury expression specifically in
the node and AME, but not PS, of tetraploid-derived Foxa2
null embryos at E7.5 [12]. One of the most highly down-
regulated genes in the Foxa2 null data set was Foxd4 (for-
Overview of the method used to derive and collect Foxa2 mutant epiblasts for analysis Figure 1
Overview of the method used to derive and collect Foxa2 mutant epiblasts for analysis.BMC Genomics 2008, 9:511 http://www.biomedcentral.com/1471-2164/9/511
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merly fkh-2). Foxd4 expression is completely lost in the
axial midline of Foxa2 null embryos at E8.5 and is also
slightly reduced in the anterior neuroectoderm (ANE)
[34]. We confirmed that expression of Foxd4 in the node
and AME at E7.5 was absent in Foxa2 null embryos (com-
pare Figures 2A and 2D; n = 6/6). In addition to known
markers of the node and AME, we also found DE markers
Sox17 [35], Trh [25,36] and Cer1 [37] were reduced in
Foxa2 null embryos, consistent with previous data that
showed loss of Foxa2 in the epiblast leads to reduction of
Cer1 [38]. Finally, we also detected reduction in genes
strongly expressed in the DE as well as in other germ lay-
ers, such as Arg1 and Cdx1 [25].
To provide further validation of the microarray results, we
performed quantitative real-time PCR (Q-PCR) on third
Table 1: Summary of node, notochord, and DE genes with reduced expression in Foxa2 mutants.
Expression Group Gene Symbol Microarray* (MGU74v2A) Microarray* (MOE430v2) Q-PCR* Reduced expression in Foxa2 
mutants by whole mount in 
situ hybridization
Known node and/or 
notochord markers
Foxd4 -2.80 -3.74 -4.64 Compare Figures 2A and 2D 
(n = 6/6)
Ref: [34]
Foxa1 -1.18 -1.56 -1.69 Ref: [10]
T -0.90 -0.78 -1.43 Ref: [10-12]
Foxa2 -1.28 -0.87 -- --
Shh -- -1.43 -- Ref: [10-12,38]
Car3 -- -1.55 -- --
Cthrc1 -- -1.45 -- --
Chrd -- -1.49 -- --
Tmprss2 -- -0.36 -- --
Dynlrb2 -- -0.69 -- --
Novel node and/or 
notochord markers
Gal -0.93 -1.58 -3.32 Compare Figures 2B and 2E 
(n = 7/7)
Prnp -0.65 -0.76 -0.30 Data not shown (n = 3/3)
Pim1 -0.63 -1.68 -- --
Smoc1 -0.20 -0.68 -- --
Gstm5 -0.48 -- -- --
Cyb561 -0.40 -- -- --
1700027A23Rik -- -1.01 -- --
Josd2 -- -1.04 -- --
Mlf1 -- -0.87 -- --
1700009P17Rik -- -1.26 -- --
Known DE markers Sox17 -0.83 -0.87 -0.58 --
Cer1 -1.40 -1.87 -2.32 Ref: [38]
Foxa2 -1.28 -0.87 -- --
Foxa1 -1.18 -1.56 -1.69 Ref: [10]
Trh -0.65 -0.79 -- --
Shh -- -1.43 -- Ref: [10-12,38]
Gprc5c -- -1.64 -- --
Cyp26a1 -- -0.40 -- --
Tmprss2 -- -0.36 -- --
Cpn1 -- -0.79 -- --
Novel DE markers Cldn4 -0.60 -- -0.40 Ref: 
(Burtscher & Lickert, 2008, 
manuscript submitted)
Itga3 -0.58 -- -0.60 Compare Figures 2C and 2F 
(n = 4/4)
Cpm -- -2.45 -- --
Efhd2 -- -0.64 -- --
Ppp1r14a -- -0.90 -- --
* values are log2 transformed ratios of Foxa2 mutant pools over wild type
Abbreviation: DE, definitive endodermBMC Genomics 2008, 9:511 http://www.biomedcentral.com/1471-2164/9/511
Page 5 of 19
(page number not for citation purposes)
Validation of genes reduced in the Foxa2 mutant by whole mount in situ hybridization Figure 2
Validation of genes reduced in the Foxa2 mutant by whole mount in situ hybridization. (A-C) Wild-type and (D-F) 
Foxa2 mutant embryos at E7.75. (A, D) Foxd4 expression is absent from node and AME, and reduced in the ANE in mutant 
embryos compared to wild-type. (B, E) Gal is completely absent from node, AME and PS in the mutant embryos compared to 
wild-type. (Note: the Foxa2 mutant embryo in (E) has some background signal due to over-staining to detect any residual Gal 
expression). (C, F) Itga3 is severely reduced in the mutant embryo compared to wild-type and is only expressed in a small area 
around the APS. Black arrowheads indicate node; black lines indicate AME; red arrowheads indicate ANE; black arrows indi-
cate DE. Scale bars are 200 μm.BMC Genomics 2008, 9:511 http://www.biomedcentral.com/1471-2164/9/511
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biological replicate pools of wild-type and Foxa2 mutant
embryos. We confirmed that the known node, AME and
DE markers described above (Foxa1, T, Foxd4, Sox17, Cer1;
Table 1 and Additional File 1) had reduced levels in the
Foxa2 mutant embryo.
Reduction of these known markers provided evidence that
our microarray-based screen could detect changes in tran-
scripts specific to organizer-derived tissues at E7.5.
Whole mount in situ hybridization screening: Phase I
Based on the presence of known node, AME or DE mark-
ers among the most highly down-regulated genes in the
Foxa2 null embryo (Table 1), we selected further genes for
expression analysis by whole mount in situ hybridization.
In the first phase of our screen, we analyzed genes based
on the criteria that they were significantly reduced in the
Foxa2 null embryo (≥ 1.5 fold decrease, as detected by the
U74Av2 array) and did not have previously published
expression patterns as early as E7.5 (n = 106, after remov-
ing redundancies; Additional File 2). After completing the
first round of screening, we found the frequency of novel,
regionally specific patterns was 13% (n = 14/106), which
was on par with previous gene expression screens at the
same stage of embryonic mouse development (e.g. Sousa-
Nunes and colleagues found 18%; n = 29/160 [23]). The
frequency of regionally specific genes with a ≥ 1.5 fold
decrease in the Foxa2 null mutant more than doubles if
the known (n = 24) and novel (n = 14) expression pat-
terns in the data set are considered together (29%; n = 38/
131; Additional File 2).
In this initial phase of the screen we found three genes
with novel expression domains in the node and/or AME:
Gal (Figures 3A, 3B), Pim1 (Figures 3C, 3D), and Prnp
(Figure 3E). Gal (galanin) encodes a peptide hormone that
controls various biological activities [39], and is expressed
in the node, AME, and PS at E7.5 (Figures 2B, 3A, and 3B).
We confirmed that Gal was completely absent in Foxa2
mutant embryos (compare Figures 2B and 2E; n = 7/7).
Gal has an intriguing expression pattern in the PS, which
is first observed in the most posterior and medial region
of the streak before it bifurcates, and is then expressed
more laterally in the posterior mesoderm (Additional File
3). At E9.0 Gal is weakly expressed in the heart and poste-
rior notochord (Additional File 3). Pim1 (proviral integra-
tion site 1) is a serine/threonine kinase [40], and is
expressed in the node and PS at E7.5 (Figures 3C, 3D),
after which its expression becomes widespread at E8.5
(Additional File 3). We found Prnp, the gene that encodes
prion protein, is expressed specifically in the node at
E7.75 (Figure 3E). This was much earlier in development
than was previously reported, which described initial
onset in the mouse embryo at E9.5 [41]. Third replicate
pool validation of Gal and Prnp levels using Q-PCR con-
firmed their reduction in Foxa2 null embryos (Table 1 and
Additional File 1). We also identified genes that, although
widespread at E7.75, had an obvious and strong expres-
sion domain in the node (Igfbp5 and Ppp1r1a; Additional
File 3).
The two novel DE expression patterns that were revealed
in the first phase of the screen were Cldn4 and Itga3. Cldn4
(claudin 4) encodes a tight junction protein that is
expressed in the anterior DE and extra-embryonic regions
at E7.25, then in lateral DE and the foregut pocket at
E7.75 (Figures 4A, 4B). Cldn4 is restricted to the gut endo-
derm and otic vesicle from E8.5–9.0 (Figures 4C, 4D).
Reduction of Cldn4 has been observed in whole mount
Foxa2  null embryos (Burtscher & Lickert, 2008, manu-
script submitted). A large-scale embryonic gene expres-
sion screen previously identified Cldn4  and  Cldn6  as
regionally restricted genes, but only Cldn6 was described
and shown at E9.5 as being expressed in the endoderm
and otic vesicle [42]. Cldn6 was also one of two DE genes
identified in a subtractive cDNA screen at E7.5 [23]. Fur-
thermore, Cldn9 was identified in a SAGE-based screen to
identify genes enriched in the DE [25]. This raises the pos-
sibility that at least part of the large claudin gene family
may have important and therefore redundant functions in
the endoderm. Itga3  (integrin alpha 3) is strongly
expressed in a lateral region of the DE at E7.5 (Figure 2C).
Itga3  is expressed throughout the notochord and gut
endoderm at E8.5 (Figure 4E and data not shown). We
confirmed Itga3 was reduced in Foxa2 null embryos (com-
pare Figures 2C and 2F; n = 4/4). Interestingly, one of the
four mutants examined still expressed some Itga3  in a
small patch at the anterior primitive streak (APS; Figure
2F). This is consistent with previous results that showed
endoderm-like cells form in tetraploid chimeric Foxa2
mutant embryos, which accumulate in the APS region due
to failure of epithelialization (Burtscher & Lickert, 2008,
manuscript submitted). Reduction of Cldn4 and Itga3 lev-
els in Foxa2 mutant embryos was confirmed using Q-PCR
(Table 1 and Additional File 1). We also found a number
of genes that had weak to no staining at E7.5, but that
showed endoderm expression at E8.5 (Cd276, Galt, Gpx2,
Pla2g7, Raet1e, Wfdc2; Additional File 3); because the E7.5
microarray screen detected these genes as being signifi-
cantly reduced, we took this to mean the in situ hybridiza-
tion lacked sufficient sensitivity at this earlier stage.
Although the first phase of our screen identified a number
of genes with expression specifically in the node at E7.5,
we wondered if our ability to detect reduction in node-
specific transcripts was at the limit of the microarray's sen-
sitivity. We considered this because the node is a very
small tissue at E7.5 (~100 cells [4]), and therefore must
contribute only a tiny fraction of the total embryonic RNA
at this stage. Given that node-specific genes could beBMC Genomics 2008, 9:511 http://www.biomedcentral.com/1471-2164/9/511
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Genes we identified that are expressed in the node at E7.5 Figure 3
Genes we identified that are expressed in the node at E7.5. (A, B) Gal and (C, D) Pim1 are expressed in the PS and 
node. (E) Prnp, (F) Cyb561, (G) Smoc1, (I) 1700027A23Rik, (J) Mlf1, (K) 1700009P17Rik, and (L) Josd2 are all specifically 
expressed in the node (Note: later at E7.75, Smoc1 is expressed in the node and more broadly in the mesoderm; Additional 
File 3). (H) Gstm5 has widespread expression throughout the embryo, but is expressed strongly in the periphery of the node. 
(A, C, I) lateral view, anterior left; (B, D) distal view, anterior top; (E-H, J-L) anterior view.BMC Genomics 2008, 9:511 http://www.biomedcentral.com/1471-2164/9/511
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present in the group of down-regulated genes with a less
than 1.5 fold change in the Foxa2 mutant, we decided to
examine a number of genes that fell below this threshold.
We screened 46 genes that fell below the threshold, and
found one additional gene expressed in the endoderm
(Igfbp3; Additional Files 3 and 4), and three expressed in
the node at E7.5; these were Cyb561 (cytochrome b-561;
Figure 3F), Smoc1 (SPARC related modular calcium binding
1; Figure 3G), and Gstm5 (glutathione S-transferase, mu 5;
Figure 3H). The frequency of regionally specific transcripts
we found in this set was slightly lower than the first phase
of the screen (9%; n = 4/46). Together these results sug-
gested that our screening threshold was appropriately set
for larger tissues in the gastrula embryo, such as the AME
and DE, but that very small tissues, such as the node, were
near the limit of detection in our experimental design.
Whole mount in situ hybridization screening: Phase II
To expand on the screen performed using the U74Av2
arrays, we rehybridized the same biological samples to the
upgraded whole genome MOE430v2 arrays. The newer
arrays had much greater coverage of the mouse transcrip-
tome, however the probe sets were also completely rede-
signed, so we could not directly compare overlapping data
from the two platforms. We did find that the MOE430v2
arrays measured the same reduction in known node, AME
and DE markers as the U74Av2 arrays (Foxa2,  Foxa1,
Foxd4, T, Sox17, Cer1, Trh; Table 1). The MOE430v2 arrays
also demonstrated greater sensitivity in detecting reduc-
tion in known node, AME and DE markers represented on
both old and new versions of the GeneChip (Shh [43],
Car3 [44], Chrd [45], Tmprss2 [46], Cpn1 [25], Cyp26a1
[25,47]; Table 1). Furthermore, changes were detected in
known node, AME and DE markers not represented on
the older version of the array (Cthrc1 [48], Dynlrb2 [49],
Gprc5c [24]; Table 1), demonstrating the increased poten-
tial to identify novel genes in our tissues of interest.
For the second phase of our screen, we analyzed genes
detected by the MOE430v2 arrays as, 1) being signifi-
cantly reduced in the Foxa2  mutant embryo (p ≤ 0.05
using a Wilcoxon paired rank test; Additional File 5), 2)
Genes we identified that are expressed in the DE Figure 4
Genes we identified that are expressed in the DE. (A) Cldn4 is expressed in the anterior DE and in extra-embryonic 
regions at E7.25, (B) in the foregut pocket, lateral DE, and 37 extra-embryonic regions at E7.75, (C-D) and in the gut endo-
derm and otic vesicle from E8.5–9.0. (E) Itga3 is strongly expressed throughout the gut endoderm at E8.5. (F) Cpm is expressed 
in the anterior DE at E7.5, (G) strongly in the foregut pocket and throughout the DE at E7.75, (H) and in the ventral aspect of 
the gut at E8.5 (Note: at longer exposure, Cpm can be seen in more DE cells; Additional File 3). (I) Ppp1r14a is expressed in the 
ventral aspect of the gut at E8.5. (J) Efhd2 is highly expressed in the rostral foregut and caudal hindgut at E8.5. (A, F) lateral 
view, anterior left; (B, G) anterior view; (C-E) lateral view; (H-J) ventral view.BMC Genomics 2008, 9:511 http://www.biomedcentral.com/1471-2164/9/511
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not included in the first phase of our screen, and 3) having
a potential functional role in embryogenesis based on the
available annotation. We screened an additional 162
genes at E7.5 (and E8.5) and found 18 (11%; n = 18/162)
had regionally specific expression patterns, consistent
with the first phase of the screen (Additional File 6). Of
these genes, four genes were expressed in the node:
1700027A23Rik (Figure 3I); Mlf1 (myeloid leukemia factor
1; Figure 3J); 1700009P17Rik (Figure 3K); and Josd2 (Jose-
phin domain containing 2; Figure 3L). We also found three
additional markers of the DE: Cpm (carboxypeptidase M),
which is expressed in the anterior DE at E7.5 (Figure 4F),
throughout the DE and strongly in the foregut pocket at
E7.75 (Figure 4G), and then mostly in the ventral aspect
of the presumptive gut at E8.5 (Figure 4H); Ppp1r14a (pro-
tein phosphatase 1, regulatory (inhibitor) subunit 14A), which
is also expressed strongly in the ventral region of the gut
at E8.5 (Figure 4I); and Efhd2 (EF hand domain containing
2), which is expressed strongly in the most rostral foregut
and caudal hindgut at E8.5 (Figure 4J). By using an
extended array platform to measure transcripts reduced in
the Foxa2 mutant embryo, we increased the depth of our
screen and found seven additional genes with novel
expression domains in the node or DE.
In total, we screened 314 unique transcripts reduced in
the Foxa2 mutant embryo. We found 10 novel expression
domains in the node and 5 in the DE. These genes are
expressed in regions of high Foxa2 activity and are there-
fore potential targets of Foxa2. Furthermore, novel node
and endoderm genes are candidates for embryo pattern-
ing and notochord formation, and novel DE genes could
have an additional role in organogenesis of the gut and its
associated organs. Further studies will elucidate the func-
tional roles of these genes, and whether or not they are
directly downstream of Foxa2.
Secondary phenotypes caused by the loss of organizer 
derivates
During our screen we found a large number of both
known and novel regionally specific genes expressed out-
side the primary tissues affected in the Foxa2  mutant
embryo. For example, based on the results of the U74Av2
array and first phase screen, we found genes expressed in
the PS, ANE, cardiac mesoderm, and vasculature (Addi-
tional Files 2 and 3). The Foxa2  mutant chimeras we
derived for this study using tetraploid complementation
have wild-type rescued VE, which allows, an albeit
smaller, PS to elongate [12]. However the APS, which is
comprised of organizer tissue and gives rise to AME [5],
does not form in these mutants. Given the important
inductive role of the organizer in patterning the gastrula
embryo (reviewed [50]), it is not surprising that we would
detect molecular defects within the streak. In fact, 14% of
the genes in the first phase of the screen were expressed in
the PS (n = 18/131; Additional Files 2 and 3). Using Q-
PCR, we confirmed that a number of these PS markers
were in fact reduced in the Foxa2 mutant at E7.5 (Wnt3a
[51,52], Wnt8a [53], Hoxa1 [54]; Additional File 1). This
led us to conclude that our screen not only detected genes
specific to the primary tissues absent in Foxa2  mutant
embryos, but also found genes in secondary tissues
affected by loss of interaction with organizer derivatives.
The ingressing mesoderm of the PS is not only an impor-
tant signaling centre for the posterior of the embryo, but
is also the site of mesodermal lineage specification. For
example, endothelial precursors of the vasculature and
cardiac mesoderm both originate within the PS [55]. We
detected a number of early markers of the embryonic vas-
culature including Tie1 [56,57] and Flt4 [58]. We went on
to confirm that Flt4 was expressed at E7.75 (Additional
File 3), earlier than was previously reported at E8.5 [58],
and is reduced in Foxa2 mutants by Q-PCR (Additional
File 1). The cells that will make up the embryonic vascula-
ture originate in the PS, and our data suggests that this
early specification step is at least partially dependent on
signals from organizer tissues.
The anterior endoderm and cardiac mesoderm develop in
close proximity to each other, both at early stages of line-
age specification and determination, as well as later dur-
ing organogenesis (reviewed [59]). Extensive work in frog
and chick embryos has explored the inductive interactions
between these two tissues, although it is less clear how
these mechanisms translate in the mouse embryo
(reviewed [60]). There is some evidence that the anterior
VE has a role in patterning cardiac precursors in the mouse
[61]. In E8.5 Foxa2 mutant embryos derived by the same
method used in this study (i.e. tetraploid complementa-
tion giving wild-type VE and a Foxa2 null epiblast), loss of
the AME and DE does not severely affect patterning of the
anterior heart field, based on the result that heart markers
Nppa and Wnt11 are not greatly reduced [62]. However,
von Both and colleagues also showed that the heart
marker Smpx was partially reduced, raising the possibility
that there is a subset of cardiac markers that are affected in
these Foxa2 mutant chimeras. Consistent with this possi-
bility, the first phase of our screen identified 6 markers of
cardiac mesoderm as reduced in the Foxa2 mutant at E7.5
(Actc1 [63], Frzb [64], Myl7 [65], Tagln [66], Tnnt2 [67],
Myl1 [68]; Additional Files 2 and 3). We went on to vali-
date reduction of Tnnt2 in the Foxa2 mutant pool using Q-
PCR (Additional File 1). This subset of cardiac markers
suggests there are some genes expressed in the anterior
heart field that are more dependent on interaction with
DE versus VE, although further analysis will be required to
understand these differential inductive roles.BMC Genomics 2008, 9:511 http://www.biomedcentral.com/1471-2164/9/511
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The ANE, or presumptive forebrain, is highly dependent
on inductive interactions with the anterior mesendoderm,
definitive and visceral endoderm during gastrulation
(reviewed [6]). Foxa2 has an important role in regulating
downstream genes in the anterior VE, and therefore main-
tenance of the underlying ANE [12,19]. However, anterior
organizer derivatives in the embryo proper also play a crit-
ical role in forebrain patterning events. When the AME is
genetically compromised, either by loss of BMP antago-
nists chordin and noggin [45] or by attenuation of Nodal
signal [69], severe defects in forebrain patterning result. A
chimeric embryo without Hhex  (formerly  Hex) in the
embryo proper results in loss of DE, and subsequently
drastic forebrain truncation [70], further highlighting the
importance of organizer derivatives in anterior patterning.
Conditional inactivation of Foxa2 strictly in the epiblast,
which leads to a phenotype similar to the Foxa2 tetraploid
chimeras used in this study, also demonstrated that loss of
organizer derivatives leads to reduction of ANE markers
Six3,  Hesx1,  Foxg1  (formerly  BF1), and Fgf8  [38]. We
detected reduction of ANE markers Six3  and  Hesx1 by
microarray in the Foxa2 mutant pool, and using Q-PCR
further validated strong reduction of Hesx1 (Additional
File 1). We also confirmed Foxd4 is reduced in the ANE of
Foxa2 mutants at E7.75 (compare Figure 2A and 2D), as
was previously shown at E8.5 [34]. Together these results
strengthen the model that tissue interaction within the
anterior of the embryo proper is required for patterning of
the forebrain, although the distinct contributions of the
AME and DE will need to be investigated further.
We propose that the tetraploid Foxa2 mutant chimera will
provide an important model for further studies on the
interactions between organizer derivates and surrounding
tissues in the gastrula embryo, and we are currently inves-
tigating the inductive effect of endoderm on heart meso-
derm.
Enrichment of Gene Ontology (GO) terms among genes 
reduced in Foxa2 mutants
As a first step towards understanding the functional rela-
tionships between genes that are differentially regulated
in Foxa2 mutant embryos, we looked for enrichment of
specific GO terms. We grouped genes as being expressed
in the primary tissues affected in Foxa2 mutants (i.e. node,
notochord, AME, DE), which are also regions of high
Foxa2 activity, and in the secondary tissues affected but
where Foxa2 is not expressed, as described above (i.e. PS,
cardiac mesoderm, ANE, vasculature). We found genes
grouped into primary and secondary Foxa2 mutant tissues
had statistically significant GO terms (p ≤ 0.01 using
GOFFA in ArrayTrack; http://www.fda.gov/nctr/science/
centers/toxicoinformatics/ArrayTrack/[71]; Additional
Files 1, 7, 8). GO terms such as "transcription factor activ-
ity" and "anterior/posterior pattern formation" were
present in both groups (Table 2 and Additional Files 7, 8),
and we took this to support the Foxa2 mutant phenotype
having specific patterning defects due to the loss of organ-
izer and its derivatives, and subsequent loss of interac-
tions with surrounding tissues. As expected, within
regions of high Foxa2 activity we found significant GO
terms such as, "morphogenesis of an epithelium", "gastru-
lation", and "notochord development" (Table 2 and
Additional File 7). Furthermore, among genes specific to
secondary tissues we found GO terms such as, "cardiac
muscle morphogenesis" and "forebrain development"
(Table 2 and Additional File 8). Most importantly, the
transcription factors we identified as being reduced in
organizer derivatives may form the basis of a Foxa2-
dependent gene regulatory network.
Prediction of putative Foxa2 target genes
One of the difficulties of using the Foxa2 mutant embryo
to identify genuine Foxa2 targets is the complete loss of
organizer-derived tissues. This makes it difficult to distin-
guish between 1) genes reduced due to the absence of tis-
sue, versus, 2) genes reduced due to the absence of their
upstream activator. To begin classifying genes into these
two distinct categories, and as a way to predict putative
Foxa2 target genes, we used two independent methods to
find conserved Foxa2 binding motifs.
We searched for Foxa2 binding motifs around all genes
reduced in Foxa2  mutants  and  expressed in regions of
Foxa2 activity (Additional Files 1, 9, 10, 11, 12). The first
algorithm utilizes a precomputed database of known
binding motifs found within conserved regions of mouse
and human promoters (oPOSSUM; http://bur
gundy.cmmt.ubc.ca/oPOSSUM/[72]). We found 9 out of
19 genes searched had conserved Foxa2 binding motifs
within a 10 kb upstream and 5 kb downstream region
around the transcriptional start site (Additional File 10).
These represent strong candidates for Foxa2 target genes,
and include both known and novel genes we identified as
expressed in the node, AME and/or DE. Importantly, we
found Foxa2 itself among this set of genes, consistent with
studies in human hepatocytes that demonstrated Foxa2
binds its own promoter for autoregulation [73]. To focus
more specifically on the gene regulatory program within
the axial mesoderm, we also found conserved Brachyury/
T binding motifs in a smaller subset of the above co-
expressed genes (n = 3/19; Additional File 11). Surpris-
ingly, one of these genes was Cer1, a gene expressed exclu-
sively in the endoderm during gastrulation, suggesting
Brachyury/T could have a role in repressing endoderm
genes within the mesoderm.
The second algorithm we used searches the entire genome
for conserved regions that contain combinations of at
least two DNA binding motifs (SynoR; http://BMC Genomics 2008, 9:511 http://www.biomedcentral.com/1471-2164/9/511
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synor.dcode.org/[74]); in this case Foxa2 and Brachyury/
T. The advantage of this approach is that it is not limited
to a specific set of genes, or the relatively small genomic
regions around genes' transcriptional start sites. We iden-
tified two of the same four genes as above (Cer1 and
Foxa2) as potential targets of Foxa2 and Brachyury/T (Fig-
ure 5A; Additional File 12). The two methods we applied
(oPOSSUM and SynoR) use different position weight
matrix databases (JASPAR and TRANSFAC, respectively),
which may explain why the predicted DNA binding
motifs found by the two programs do not overlap. We
combined our validated Foxa2 mutant microarray data,
Table 2: Genes specific to affected tissues in Foxa2 mutants are enriched for Gene Ontology (GO) terms.
Affected tissues GO Term Specific Term GO ID P value* 
(Average)
E value Gene Hits 
(Number)
Gene Hits 
(Symbols)
Primary: Molecular 
function
transcription factor 
activity
GO:0003700 0.002335 5.08 5 Foxa1
Foxa2
-node Foxd4
-notochord Sox17
-anterior T
mesendoderm Biological 
process
anterior/posterior 
pattern
formation
GO:0009952 0.000362 21.11 3 Cer1
-definitive 
endoderm
Biological 
process
morphogenesis of an 
epithelium
GO:0002009 0.000432 19.87 3 Foxa2
T
Foxa1
Foxa2
T
Biological 
process
gastrulation GO:0007369 0.003025 24.25 2 Cer1
Foxa2
Biological 
process
notochord 
development
GO:0030903 0.006329 157.63 1 T
Secondary: Molecular 
function
transcription factor 
activity
GO:0003700 0.000053 4.49 10 Cdx1
Foxb1
-primitive streak Gbx2
-cardiac 
mesoderm
Hesx1
-anterior 
neuroectoderm
Hoxa1
-vasculature Meis1
Meox1
Nkx1-2
Six3
Tbx6
Biological 
process
anterior/posterior 
pattern formation
GO:0009952 0 21.77 7 Aldh1a2
Dll1
Gbx2
Hoxa1
Meox1
Six3
Wnt3a
Biological 
process
cardiac muscle 
morphogenesis
GO:0055008 0.00012 116.09 2 Actc1
Tnnt2
Biological 
process
forebrain 
development
GO:0030900 0.000392 11.51 4 Aldh1a2
Fabp7
Six3
Wnt3a
*significance for GO term enrichment: p ≤ 0.01BMC Genomics 2008, 9:511 http://www.biomedcentral.com/1471-2164/9/511
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A network model for Foxa2-dependent gene regulation in organizer derivatives Figure 5
A network model for Foxa2-dependent gene regulation in organizer derivatives. (A) An example of binding motif 
prediction results visualized using the UCSC genome browser; http://genome.ucsc.edu/[105]. Conserved Foxa2 and Brachyury/
T binding motifs were found in the 10 kb region upstream of the endoderm-specific Cer1 gene. (B) A hypothetical network 
model based on existing genetic data (see Discussion for details and references), and binding motif predictions around putative 
Foxa2 target genes (Additional Files 1, 9, 10, 11, 12). Brachyury/T is active in node, notochord and axial mesendoderm (ND/
NC/AME), but not in definitive endoderm (DE). The transcription factors Foxa2, Brachyury/T, Noto, Foxa1, and/or Foxd4 
could regulate putative ND/NC/AME target genes; Foxa2, Foxa1, and/or Sox17 could regulate DE target genes. We propose a 
role for Brachyury/T in repression of DE targets in the ND/NC/AME lineages. Foxa2 likely regulates itself in both ND/NC/
AME and DE. (Note: the network diagram was created using BioTapestry; http://www.biotapestry.org/[106]).BMC Genomics 2008, 9:511 http://www.biomedcentral.com/1471-2164/9/511
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predictions of conserved Foxa2 and Brachyury/T binding
motifs, as well as existing genetic data, to build a gene reg-
ulatory network model in the organizer and its derivates
(Figure 5B), the details of which will be outlined in the
following discussion.
Discussion
Microarray analysis of Foxa2 mutant gastrula embryos
Functionally based expression profiling of the early
mouse embryo is emerging as a powerful method to elu-
cidate the regulatory networks that underlie developmen-
tal programs. Comparison of the transcriptional profile
between wild-type and mutant embryos has been done
using subtractive cDNA libraries [26], and more recently
using microarrays; for example, to study Wnt signaling
during gastrulation using conditional β-catenin mutants
[75], the pharyngeal region of Tbx1 mutants [76], and the
mid-hindbrain organizer region in Pax2 mutants [77]. We
have used microarrays for expression profiling of wild-
type and Foxa2  mutant embryos at E7.5, which fail to
form organizer-derived tissues, including the node, AME,
and DE. We were able to identify both known and novel
markers that were specific to these tissues, based on their
reduction or absence in the Foxa2 mutant.
Whole mount in situ expression screening
We found known markers of the node, AME, and DE had
a ≥ 1.5 fold decrease in the Foxa2 mutant, and this enabled
us to set a threshold for the first phase of the whole mount
in situ hybridization screen (n = 106). We then examined
a number of genes that fell below this threshold to evalu-
ate the sensitivity of our experimental design (n = 46). We
found that genes expressed in the node, because it is a
small tissue and represents a small fraction of the total
RNA, were difficult to detect by differential expression lev-
els. Finally, we rehybridized our original biological sam-
ples to an updated microarray to expand the depth of our
screen, and chose additional transcripts for analysis (n =
162). This second phase of our whole mount in situ
hybridization screen more than doubled our total cover-
age of unique genes (n = 314). From the combination of
these various approaches, we found 10 novel expression
patterns in the node and 5 in the DE.
Highly dynamic regional expression patterns within the 
developing primitive gut
Before this and other recent screens in the early mouse
embryo [23-25,46], there were very few markers available
that were specific to the definitive endoderm. Two of these
screens extended their design to isolate regionally specific
transcripts along the anterior-posterior axis of the gut
[25,46]. Together, all of these markers will be critical for
understanding the regional patterning of the gut during
development, as well as for in vitro differentiation of ES
cells into endoderm lineages for therapeutic use. Signifi-
cant recent progress has also been made in understanding
the fate map of gastrulation stage DE and how it gives rise
to later regions of the gut endoderm [78-81]. From this
data a highly dynamic model of endoderm formation is
emerging.
The next challenge will be to understand the different spa-
tial and temporal requirements of this myriad of endo-
derm genes. For example, there are endoderm genes that
are only expressed at early stages of endoderm develop-
ment (Cer1, [37]), and those that are uniformly expressed
early on and then become highly regionalized (Trh, [36]).
We have identified genes that later at E8.5 are restricted to
the midgut and hindgut (Ppp1r14a; Figure 4I), as have
others previously (Sox17, [35]; Tmprss2, [46]), highlight-
ing anterior-posterior differences in the developing gut
tube. Furthermore, the dorsal-ventral aspect of the primi-
tive gut also has differential gene expression, as shown by
the ventrally enriched genes we and others have identified
(Cpm; Figure 4H; Pyy, [25]; Trh, [36]). Finally, we have
also identified genes that appear to be expressed through-
out many regions and stages of DE development (Cldn4;
Figures 4A, 4B, 4C, 4D), which are structurally important
for the development of the gut epithelium. A major out-
standing question is whether or not these early regional
expression patterns in the endoderm are predictive of later
pattern in the gut and its associated organs.
Loss of organizer induction in the Foxa2 mutant embryo
Our microarray analysis of Foxa2 mutant embryos derived
by tetraploid aggregation represents a complete molecular
profile of a gastrula embryo that has developed with all
tissues intact, except the organizer and its derivatives. The
functional nature of this screen has allowed us to detect
not only primary organizer specific genes (e.g. node, noto-
chord, and DE), but also the secondary reduction of tis-
sues that rely on interaction with the organizer (e.g.
cardiac mesoderm, PS, vascular progenitors, ANE).
Importantly, all of these secondary tissues still form in the
Foxa2 mutant, so it is not their specification that is com-
promised. In fact, the first studies that either genetically or
physically ablated the organizer in the mouse were sur-
prising because of how well the embryo was still patterned
[10,11,82,83]. Significantly, there appear to be subsets of
genes within these secondary tissues that are more reliant
on organizer interactions than others; for example, we
observed reduction in various cardiac mesoderm markers,
whereas others have shown that there are other cardiac
markers that are not reduced in these mutants [62]. This is
suggestive of genetic programs that are more dependent
on either a regulative or determinative mode of develop-
ment. The analysis of the Foxa2 mutant we present here
may point to a future direction in organizer research – the
molecular basis of how the organizer functions to subtly
refine its adjacent tissues.BMC Genomics 2008, 9:511 http://www.biomedcentral.com/1471-2164/9/511
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Building a network of Foxa2-dependent gene regulation in 
organizer derivatives
Although our understanding of the gene regulatory net-
works involved in vertebrate development is at an early
stage, significant progress has been made in sea urchin
[84], Drosophila [85], and ascidian embryos [86]. These
invertebrate models provide an invaluable framework for
predicting how more complex organisms must also organ-
ize genetic networks. Our interest is focused on specifica-
tion of cell lineages that originate in the mouse gastrula
organizer, and in particular how Foxa2 functions as a reg-
ulator within these tissues. Foxa2 is expressed early in the
organizer and then throughout its development, as this
population gives rise to axial mesoderm (notochord), DE
(gut), and ventral neuroectoderm (floor plate) [5]. This
raises the interesting question of how Foxa2 maintains
regulation in distinct but closely associated lineages that
segregate during gastrulation. To begin addressing this
complex problem, we have built a putative gene regula-
tory network based on potential Foxa2 target genes
(experimentally validated by either Q-PCR or whole
mount in situ hybridization in Foxa2 mutants) that can be
used as a testable model in future studies.
Studies in sea urchin embryos have shown that gene regu-
latory networks specify cell lineages in a number of ways
[87], which include: 1) a means for initial acquisition of
identity, 2) feedback loops to stabilize a regulatory state,
3) exclusion of alternate states, 4) production of a signal
that is required for itself and adjacent cells, and 5) lineage-
specific activation of genes. We present our network
model with these concepts in mind.
A delicate balance between Wnt and Nodal pathways is
required for the establishment and function of the verte-
brate organizer (reviewed [50]). There is evidence that the
Wnt/β-catenin pathway indirectly regulates Foxa2 through
Tead proteins that bind a node-specific Foxa2 upstream
enhancer [88]. Previous genetic studies have shown that
Nodal signal, mediated in the nucleus through a Foxh1-
Smad complex, is also upstream of Foxa2 in organizer lin-
eages [89,90]. Our microarray results confirm this, as
Foxh1 levels are not changed in Foxa2 mutants; a result
that was further validated using Q-PCR (Additional File
1). Conversely, we also validated that Foxa2  levels are
reduced in Foxh1  mutants at E7.5 (data not shown).
Nodal-Foxh1-Smad is likely one of the mechanisms that
organizer cells use to interpret their environmental cues
for initial acquisition of identity.
Once an initial identity has been established in a cell lin-
eage it must be stabilized. One mechanism for this is a
positive feedback loop involving transcriptional regula-
tors that reinforce each other's expression [87]. We found
evidence for this using Foxa2 and Brachyury/T binding
motif predictions; Brachyury/T may be regulated by Foxa2,
and Foxa2 may be regulated by itself and Brachyury/T (Fig-
ure 5B; Additional File 12). Consistent with this idea, we
have previously found that Foxa2 is expressed in AME pre-
cursors in the epiblast, which upregulate Brachyury/T pro-
tein after epithelial-to-mesenchymal transition (Burtscher
& Lickert, 2008, manuscript submitted). This AME popu-
lation stays positive for Foxa2 and Brachyury/T protein
during the development of the axial mesoderm and ante-
rior endoderm populations. Also, Foxa2 and Brachyury/T
likely regulate Foxa1, another axial mesendoderm tran-
scription factor. The presence of all three factors in a cell's
nucleus would help "lock in" this particular fate. Further-
more, Foxa2 genetically interacts with a number of other
transcription factors (i.e. Noto [91], Lhx1 [92], Otx2 [93],
Gsc [94]) and further investigation may reveal that feed-
back loops work to reinforce cell fates in these contexts as
well.
Another important step in specifying a given lineage is the
exclusion of alternate cell fates. For example, the homeo-
domain transcription factor Noto is critical for promoting
axial mesoderm fate (notochord) and repressing paraxial
mesoderm fate (somite) [91,95]. Also, β-catenin has a role
in promoting axial mesendoderm towards an endoderm
fate, while repressing mesoderm fate [96]. Synergism
between Foxa2 and Brachyury/T has been demonstrated
in both ascidian and Xenopus for promotion of notochord
fate [97,98], yet surprisingly we found conserved Foxa2
and Brachyury/T binding motifs associated with the endo-
derm gene Cer1 (Figure 5; Additional File 12). As Brachy-
ury/T is not expressed in the endoderm, it would suggest
that Brachyury/T might actively repress endoderm fate
within the axial mesoderm. Studies in ascidian embryos
have shown that the converse is true; that Brachyury/T is
repressed in endoderm lineages (by β-catenin), which has
the effect of inhibiting notochord fate [99]. There is evi-
dence that Foxa2 can function as a repressor [31], so it is
possible that Foxa2 may also work to exclude alternate
fates. It will be interesting to explore further how Foxa2
and Brachyury/T interact with each other and their down-
stream targets, both positively and negatively, to sort out
the multiple lineages that are produced during gastrula-
tion.
A given cell lineage in the developing embryo does not
develop in isolation, and proper specification usually
involves production of a signal for maintenance of itself
and patterning of adjacent tissues [87]. In the notochord,
Shh is the most likely candidate for this lineage-specific
signal. It is thought to have an autocrine function, in that
the notochord is formed but not maintained in its
absence, as well as a paracrine function, as it is necessary
and sufficient for patterning of the adjacent ventral neural
tube [43,100]. Foxa2 is a key regulator of Shh in both theBMC Genomics 2008, 9:511 http://www.biomedcentral.com/1471-2164/9/511
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notochord and the floor plate [17,18], connecting the
production of a notochord-specific signal with our emerg-
ing Foxa2-dependent gene regulatory network.
The culmination of lineage specification is the activation
of a host of genes that enable cells to perform their desig-
nated function. The notochord's two primary functions
during embryogenesis are signaling and structural
(reviewed [101]), which in the mouse embryo can be
broadly assigned to earlier and later stages, respectively.
Our Foxa2 mutant screen was performed at E7.5, which
we expect is too early to detect disruption of the structural
genes expressed later in differentiation of mature noto-
chord. Our binding motif predictions identified novel
node genes Mlf1, Pim1, and Smoc1  as potential down-
stream targets of Foxa2 in the notochord, as well as Cer1
in the endoderm (Figure 5B; Additional File 12). We
could detect reduced Shh levels, and therefore one of the
direct signaling targets of Foxa2. However, because of the
early stage of our screen, we would predict that detectable
Foxa2 targets would be in the top tier of the axial mesen-
doderm gene regulatory network, and few of the noto-
chord differentiation genes would have been activated.
This is supported by the identification of a number of
other transcription factors among our group of putative
Foxa2 targets (Additional File 12).
Conclusion
We have conducted functional microarray and expression
pattern screens based on the Foxa2 mutant embryo. These
screens detected differentially regulated genes because of
the absence of a critical transcription factor and pheno-
typic loss of organizer-derived tissues in the early embryo.
These data have provided not only novel regionally spe-
cific gene expression patterns in the node, AME and DE,
but also putative downstream targets of Foxa2 and poten-
tial new genes regulating organizer biology. This data has
allowed us to build a model of the gene regulatory net-
work involved in Spemann/Mangold organizer forma-
tion.
Note Added in Proof
While this manuscript was in preparation, Schweickert
and colleagues identified Galanin in a screen for asymmet-
rically expressed genes, based on its expression pattern in
the heart. They also noted its expression in the node,
notochord and PS between E7.5 and E8.5 [102].
Methods
Microarrays
Tetraploid embryos were derived as previously described
[29,30] using Foxa2 null ES cells [12]. Wild-type embryos
were collected from timed matings of ICR mice. Wild-type
or tetraploid embryos were collected at E7.5 and staged
accordingly [103]. Embryos were between mid-streak and
head-fold stages and the extra-embryonic regions were
removed by dissection. The embryo proper, including
extra-embryonic tetraploid-derived VE, was retained and
multiple samples were pooled for total RNA isolation
using Trizol reagent (Invitrogen). Numbers of E7.5
embryos collected and pooled were as follows: wild-type
1 (n = 53), wild-type 2 (n = 50), Foxa2 null 1 (n = 53),
Foxa2 null 2 (n = 48) (Additional File 13 details the stag-
ing of embryos). Total RNA from each of the four embryo
pools was processed for Affymetrix U74Av2 GeneChip
microarrays, as previously described [75]. The same
hybridization mixtures of these biological samples were
later used for hybridization to the upgraded Affymetrix
MOE430v2 GeneChip microarrays. All microarray data
has been submitted to the Gene Expression Omnibus
(GEO) at NCBI (accession number: GSE5424).
Data analysis
Affymetrix MAS 5.0 software was applied to the U74Av2
GeneChip data to target normalize the global expression
level to 1000, and provide present, absent and fold change
calls in cross-comparisons of all replicate mutant samples
over the two replicate wild-type samples. Next probe sets
with absent calls in all samples were removed from the
data set. As well, all samples with illogical calls were also
removed, for example a probe set with an increase call that
was called absent in the sample with the higher level of
expression. Lastly, we filtered the data to include only
probe sets that showed a statistical change call in two or
more (2/4) of the cross comparisons.
MOE430v2 GeneChips were analyzed as follows in the R
statistical programming language (R Core Development
Team, 2006; Additional File 5). Probeset summaries were
calculated according to the MAS 5.0 algorithm. Logarith-
mic summary values were normalized by the loess
smoother [104] applied to the M-A scale transform. Statis-
tical testing for differential expression between mutant
and wild-type was performed on single probe level taking
the duplicate chips into account employing the Wilcoxon
paired rank test. The p-value threshold was adjusted by
either family-wise error rate (FWER, Bonferroni proce-
dure) or the false discovery rate (FDR, Bejamini-Hochberg
technique). Significant probesets were tested for enrich-
ment of GO terms by the hypergeometric distribution
testing with the annotation as available from the GO con-
sortium on March 25th, 2005.
Whole mount in situ hybridization
Whole mount in situ hybridization on E7.5–9.0 mouse
embryos was performed as previously described [96],
however digestion with proteinase K was replaced with a
20 minute 3% hydrogen peroxide incubation step. Anti-
sense RNA in situ probes were transcribed accordinglyBMC Genomics 2008, 9:511 http://www.biomedcentral.com/1471-2164/9/511
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from sequence-verified cDNA clones (see Methods and
Additional Files 1, 2, 4, 6). Described expression patterns
are representative of at least three or more stage-matched
embryos.
Quantitative real-time PCR
A third biological replicate pool each of wild-type (n = 47)
and Foxa2 null (n = 33) embryos were collected, as above,
for independent validation of gene expression levels using
quantitative real-time PCR. Total RNA was isolated using
Trizol reagent (Invitrogen) and provided the template for
subsequent cDNA synthesis (Qiagen QuantiTect Rev.
Transcription Kit). Quantitative real-time PCR was per-
formed using the Roche LightCycler 480 and SYBR green
reagent. See Additional File 1 for primer sequences and
details. Transcripts were measured as a ratio of Foxa2 null
levels compared to wild-type and normalized to endog-
enous Hprt levels as a reference.
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